OpenLegislation

Division 1.1.2

United Kingdom

Original text. Later amendments are not shown.

Diamino pyrimidine derivatives

Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissuesOther provisions
BaquiloprimBaquiloprimBovine10 μg/kgFat
300 μg/kgLiver
150 μg/kgKidney
30 μg/kgMilk
Porcine40 μg/kgSkin and fat
50 μg/kgLiver
50 μg/kgKidney
TrimethoprimTrimethoprimBovine50 μg/kgMuscle
50 μg/kgFat
50 μg/kgLiver
50 μg/kgKidney
50 μg/kgMilk
Porcine50 μg/kgMuscle
50 μg/kgSkin and fat
50 μg/kgLiver
50 μg/kgKidney
Equidae100 μg/kgMuscle
100 μg/kgFat
100 μg/kgLiver
100 μg/kgKidney
Poultry50 μg/kgMuscle
Not for use in animals from which eggs are produced for human consumption50 μg/kgSkin and fat
50 μg/kgLiver
50 μg/kgKidney
Fin fish50 μg/kgMuscle and skin in natural proportions